Cenerimod ’s Development Targets Severe SLE Disease Activity Cenerimod ’s Development Targets Severe SLE Disease Activity
Novel S1P1 receptor modulator cenerimod shows impact on disease activity in lupus, with more pronounced benefits in those with more severe disease.MDedge News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - May 26, 2023 Category: Transplant Surgery Tags: Rheumatology News Source Type: news

Severe HCQ Nonadherence Linked to Worse SLE Outcomes Severe HCQ Nonadherence Linked to Worse SLE Outcomes
Severe nonadherence to hydroxychloroquine in patients with lupus is associated with an increased risk of flare, organ damage, and mortality within 5 years, leading experts to advise routine testing.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - May 26, 2023 Category: Dermatology Tags: Rheumatology News Source Type: news

IVX Health secures lease in 2 retail spaces in Broward County
The centers treat patients with chronic health conditions such as arthritis, lupus and asthma. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 25, 2023 Category: Pharmaceuticals Authors: Erik Bojnansky Source Type: news

Early Remission in Lupus Nephritis May Not Bar Advanced CKD Early Remission in Lupus Nephritis May Not Bar Advanced CKD
Patients with lupus nephritis who achieve complete remission within 1 year of starting treatment can still develop advanced chronic kidney disease within a few years.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 23, 2023 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Lupus Landmark Study Aims for Personalized Medicine Goals Lupus Landmark Study Aims for Personalized Medicine Goals
The Lupus Landmark Study was designed as part of the Lupus Nexus, a combination registry, biorepository, and data portal.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 23, 2023 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Lupus Nephritis Treatment Response Biomarkers Gain Ground Lupus Nephritis Treatment Response Biomarkers Gain Ground
A panel of protein biomarkers in urine could achieve better identification of lupus nephritis patients who are likely to respond to treatment.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 19, 2023 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Janssen to Highlight Scientific Advances and Commitment to Transform Cancer Care at ASCO and EHA with More than 90 Presentations Showcasing Robust, Differentiated Portfolio and Pipeline in Hematologic Malignancies and Solid Tumors
This study evaluates an investigational combination regimen of IMBRUVICA® (ibrutinib) plus venetoclax (I+V) for newly diagnosed chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), (Abstracts #7535 and #P617, respectively).Advancing the Science of Solid Tumors Through Precision MedicineJanssen’s continued innovation in solid tumors focuses on advancing precision medicine options for patients with biomarker-driven disease who have limited targeted treatment options and moving patients into earlier lines of therapy when treatments may be more effective. Lung CancerAn oral presentation will report ...
Source: Johnson and Johnson - May 18, 2023 Category: Pharmaceuticals Tags: Innovation Source Type: news

Solving Data Collection Challenges in Lupus Trials with the Electronic...
In this free webinar, learn how to overcome challenges innate to common Lupus assessment including inconsistencies, documenting supportive findings and scoring algorithms. The featured speakers will...(PRWeb May 18, 2023)Read the full story at https://www.prweb.com/releases/solving_data_collection_challenges_in_lupus_trials_with_the_electronic_lupus_assessment_suite_upcoming_webinar_hosted_by_xtalks/prweb19345394.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 18, 2023 Category: Pharmaceuticals Source Type: news

‘ What Price Was My Father ’ s Life Worth? ’ Right-Wing Doctors Are Still Peddling Dubious COVID Drugs
Julie Moore keeps an orange plastic bottle on her desk in Gas City, Indiana, with 14 round white pills. The other 21, she says, killed her father. Moore remembers laughing when she first heard on the news that people were taking ivermectin, an anti-parasitic drug commonly used as a livestock dewormer, to treat COVID-19. She never expected her father, a career pharmacist, to become one of them. Over the course of the pandemic, Moore’s father started watching online videos of doctors in white coats who claimed that alternative COVID treatments were being used effectively in India. He told his skeptical children that th...
Source: TIME: Health - May 15, 2023 Category: Consumer Health News Authors: Vera Bergengruen Tags: Uncategorized feature Misinformation & Disinformation uspoliticspolicy Source Type: news

Lupus & kcr 2023 lupus & kcr 2023
Read clinically focused news coverage of key developments from LUPUS& KCR 2023Medscape Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 12, 2023 Category: Consumer Health News Tags: None Conference Coverage Source Type: news

Call for psychosis treatment overhaul after evidence of autoimmune trigger
Patients to be treated with medicines used for arthritis and lupus in relaunch of pioneering UK trialOne of the UK ’s leading psychiatrists is calling for an overhaul of the diagnosis and treatment of psychotic disorders following evidence that a small but significant fraction of cases could be triggered by an autoimmune response.Speaking before the relaunch of a groundbreaking trial in which psychosis patients are being treated with medicines normally reserved for autoimmune conditions such as arthritis and lupus, Prof Belinda Lennox, the head of psychiatry at the University of Oxford, said she hoped the work would pave...
Source: Guardian Unlimited Science - May 12, 2023 Category: Science Authors: Hannah Devlin Science correspondent Tags: Mental health Psychiatry Society Medical research Science UK news Source Type: news

Lupus is a mysterious, brutal disease. Here's how you can join the fight against it
May 10 is World Lupus Day, a global annual event that calls attention to lupus's impact on people worldwide to improve the quality of life for people impacted by the disease. (Source: CNN.com - Health)
Source: CNN.com - Health - May 10, 2023 Category: Consumer Health News Source Type: news

Headache and Systemic Lupus Erythematosus Headache and Systemic Lupus Erythematosus
Headache occurs frequently in patients with systemic lupus erythematosus. This review describes the epidemiology, differential diagnosis, and management of headaches in patients with SLE.Headache (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 9, 2023 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Low Disease State for Childhood Lupus Approaches Validation Low Disease State for Childhood Lupus Approaches Validation
A new childhood version of the Lupus Low Disease Activity State has been purposefully developed to align with the criteria already used for adults.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - May 8, 2023 Category: Dermatology Tags: Rheumatology News Source Type: news

Supreme Court ’s Dobbs Decision Blocks Non-Pregnant Females From Critical Medication For Lupus, Rheumatoid Arthritis, Other Diseases
The Dobbs decision blocks non-pregnant female patients from receiving medications, like methotrexate, used to treat their autoimmune diseases. This could be just the beginning of government overreach for girls, women, and their families. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 8, 2023 Category: Pharmaceuticals Authors: Ellen Matloff, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news